Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$57.00

Role of complexin II in astrocytes

EF 2010-11

Résumé
Complexins constitute a family of cytosolic proteins that are involved in the regulation of neurotransmitter release. Complexin I is considered a marker of inhibitory synapses, while complexin II (Cpx II) labels predominantly excitatory nerve terminals. Although it is clear that neurotransmitter release occurs at the presynaptic terminal, recent evidence suggest that astrocytes possess the same neuronal machinery used for synaptic vesiclar release. Since Cpx II is an integral part of this neuronal machinery, we plan to study its role in the release of glutamate from these glial cells. The research project will address hypotheses that consider 1) Cpx II is present in astrocytes and regulates the release of glutamate from these cells, 2) Cpx II II modulates synaptic neurotransmission, 3) Oxidative stress influences Cpx II-mediated glutamate release, and 4) Cpx II regulates a novel and distinct form of astrocytic glutamate release that is different to other types of glutamate release operating under conditions of pathology. These issues will be addressed using primary cultures of astrocytes and neurons, in which knockdown of Cpx II gene expression will be produced and consequential genomic effects of altered Cpx II function will be identified in astrocytes and neurons along with energy metabolism changes. We are confident this research project will not only increase our understanding of the role of complexins in astrocyte function, but will also provide new insight into the significance of glutamate release from these cells, the influence of this process on excitatory neurotransmission, and its vulnerability under pathological conditions.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
261915-2009
Name nom
Hazell, Alan
Department département
Médecine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
57
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5102
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Inter-cellular communication
Research subject fr
Communication inter-cellulaire
Partie
2
Nb partie
2
Application title
Role of complexin II in astrocytes
Keyword
NSERC
Application summary
Complexins constitute a family of cytosolic proteins that are involved in the regulation of neurotransmitter release. Complexin I is considered a marker of inhibitory synapses, while complexin II (Cpx II) labels predominantly excitatory nerve terminals. Although it is clear that neurotransmitter release occurs at the presynaptic terminal, recent evidence suggest that astrocytes possess the same neuronal machinery used for synaptic vesiclar release. Since Cpx II is an integral part of this neuronal machinery, we plan to study its role in the release of glutamate from these glial cells. The research project will address hypotheses that consider 1) Cpx II is present in astrocytes and regulates the release of glutamate from these cells, 2) Cpx II II modulates synaptic neurotransmission, 3) Oxidative stress influences Cpx II-mediated glutamate release, and 4) Cpx II regulates a novel and distinct form of astrocytic glutamate release that is different to other types of glutamate release operating under conditions of pathology. These issues will be addressed using primary cultures of astrocytes and neurons, in which knockdown of Cpx II gene expression will be produced and consequential genomic effects of altered Cpx II function will be identified in astrocytes and neurons along with energy metabolism changes. We are confident this research project will not only increase our understanding of the role of complexins in astrocyte function, but will also provide new insight into the significance of glutamate release from these cells, the influence of this process on excitatory neurotransmission, and its vulnerability under pathological conditions.